British Journal of Cancer
Overview
The British Journal of Cancer is a renowned peer-reviewed medical journal that focuses on all aspects of cancer research, including prevention, diagnosis, treatment, and survivorship. It publishes high-quality studies, reviews, and commentaries to advance our understanding of cancer biology, genetics, epidemiology, and therapeutics. With its broad scope and rigorous scientific approach, the journal serves as a valuable resource for researchers, clinicians, and policymakers in the fight against cancer.
Details
Details
Abbr.
Br J Cancer
Start
1947
End
Continuing
Frequency
Semimonthly
p-ISSN
0007-0920
e-ISSN
1532-1827
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 280
272
SJR / Ranks: 600
3000
CiteScore / Ranks: 699
14.10
JIF / Ranks: 578
8.8
Recent Articles
1.
Grancher A, Beaussire-Trouvay L, Vernon V, Dutherage M, Blondin V, Elie C, et al.
Br J Cancer
. 2025 Mar;
PMID: 40089635
Background: Circulating tumor DNA variations (∆ctDNA) were reported to be associated with treatment efficacy in metastatic colorectal cancer (mCRC). The present study evaluated ∆ctDNA according to first-line treatment intensity. Methods:...
2.
Caiazza F, McGowan P, Mullooly M, Murray A, Synnott N, ODonovan N, et al.
Br J Cancer
. 2025 Mar;
PMID: 40087384
No abstract available.
3.
Tang F, Zhu Y, Shen J, Yuan B, He X, Tian Y, et al.
Br J Cancer
. 2025 Mar;
PMID: 40069574
Background: The heterogeneity of tumors significantly impacts on colorectal cancer (CRC) progression. However, the influence of this heterogeneity on the spatial architecture of CRC remains largely unknown. Methods: Spatial transcriptomic...
4.
Lin H, Jeon A, Chen K, Lee C, Wu L, Chong S, et al.
Br J Cancer
. 2025 Mar;
PMID: 40057667
Hepatocellular carcinoma (HCC) is the sixth leading cancer worldwide and has complex pathogenesis due to its heterogeneity, along with poor prognoses. Diagnosis is often late as current screening methods have...
5.
Skriver C, Cronin-Fenton D, Borgquist S, Hansen Viuff J, Alkner S, Ryden L, et al.
Br J Cancer
. 2025 Mar;
PMID: 40057666
Background: Statins have been suggested to protect against breast cancer risk, but the observational evidence is inconclusive. We examined the association between statin use and breast cancer incidence among women...
6.
Leung J, Chiu H, Taneja R
Br J Cancer
. 2025 Mar;
PMID: 40055485
Paediatric oncogenesis is tightly intertwined with errors in developmental processes involving cell specification and differentiation, which are governed by intricate temporal epigenetic signals. As paediatric cancers are characterised by a...
7.
Tapiainen V, Sirnio P, Elomaa H, Karjalainen H, Aijala V, Kastinen M, et al.
Br J Cancer
. 2025 Mar;
PMID: 40055484
Background: SARIFA (Stroma AReactive Invasion Front Areas), defined as the direct contact between a tumour cell cluster and adipose cells at the invasion margin, has been proposed as a prognostic...
8.
Jeng L, Shih F, Liao Y, Shyu W, Teng C
Br J Cancer
. 2025 Mar;
PMID: 40050434
Background: Dendritic cell (DC) vaccine is a promising immunotherapy for hepatocellular carcinoma (HCC) via triggering antigen-specific anti-tumor immunity. Hypoxia contributes to higher level and broader spectrum of antigen expression in...
9.
Li G, Ma B, Zhang S, Liu R, Siddiqi I, Sali A, et al.
Br J Cancer
. 2025 Mar;
PMID: 40044981
Background: PI3K pathway activation is a common and early event in prostate cancer, from loss of function mutations in PTEN, or activating mutations in PIK3Ca or AKT leading to constitutive...
10.
Hohenberger P, Rathmann N, Busing K, Menge F, Jakob J, Pink D, et al.
Br J Cancer
. 2025 Mar;
PMID: 40044980
Background: Hepatic metastases of GIST might be the dominant site of progression and resistant to available tyrosine kinase inhibitors (TKIs). Selective internal radiation therapy (SIRT) offers treatment by intratumoral radiation...